Regulatory Compliance

AFSP Advocates Press Congress on $549.6M Lifeline Funding Push

Image
AFSP Advocates Press Congress on $549.6M Lifeline Funding Push

Washington – September 17, 2026 -- Seventeen Volunteer Advocates from the American Foundation for Suicide Prevention (AFSP) will meet with members of Congress from September 16-18 to push for sustained federal funding and pending legislation on suicide prevention, arriving weeks after Congress passed the Youth Poisoning Protection Act (H.R. 1442/S. 289), which now awaits presidential signature.

Advocates from 14 states demand $549.6 million for the 988 Suicide & Crisis Lifeline

The delegation, sponsored for a second year by AFSP's Illinois chapter during National Suicide Prevention Month, is lobbying for robust funding of the 988 Lifeline at $549.6 million, a $38 million allocation for the CDC's Comprehensive Suicide Prevention Program (CSP), and $2.548 billion for the National Institute of Mental Health.

Acarix Study Shows Acoustic Sensor Rivals Blood Test for Heart Failure

Image
Acarix Study Shows Acoustic Sensor Rivals Blood Test for Heart Failure

Oklahoma City – September 17, 2026 -- Acarix AB announced that a peer-reviewed study published in PLOS Digital Health found its seismocardiography (SCG) technology can detect heart failure with diagnostic accuracy comparable to NT-proBNP, the current standard blood test, while producing significantly fewer false positives.

SCG algorithm matches blood test accuracy with far higher specificity

Researchers at Aalborg University Hospital, Aarhus University Hospital and Odense University Hospital enrolled 218 patients, including 198 referred by general practitioners for suspected heart failure and 20 with previously confirmed HFrEF. Using machine learning, the team built two SCG-based scores: an 'AnyHF-score' to flag heart failure of any type, and an 'HFrEF-score' targeting the more severe reduced-ejection-fraction form of the condition.

Olin-Huntsman Merger Clears US Antitrust Review, Nears Closing

Image
Olin-Huntsman Merger Clears US Antitrust Review, Nears Closing

Clayton, Mo. and The Woodlands, Texas – – September 17, 2026 -- Olin Corporation (NYSE: OLN) and Huntsman Corporation (NYSE: HUN) confirmed that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act has expired, clearing a key regulatory hurdle for their planned merger of equals.

HSR clearance removes a major closing condition for the chemical sector merger

The expiration satisfies one of the primary conditions required to close the transaction, though the deal still awaits additional regulatory approvals that are currently underway.

Shareholders of both companies approved the deal on September 17, 2026

Investors from Olin and Huntsman overwhelmingly backed the merger of equals at their respective shareholder votes, clearing the corporate governance path toward completion.

Qualcomm-Amazon AI Deal, DOE $1.9B Nuclear Loan Top Week's News

Image
Qualcomm-Amazon AI Deal, DOE $1.9B Nuclear Loan Top Week's News

New York – September 17, 2026 -- Qualcomm and Amazon unveiled a multi-generational product collaboration to build next-generation AI data center infrastructure, combining Amazon's cloud-scale compute with Qualcomm's power-efficient silicon design.

Qualcomm and Amazon target AI data center bottlenecks

The partnership addresses surging demand for compute, storage, networking and memory bandwidth as AI workloads scale exponentially, pairing Amazon's infrastructure with Qualcomm Technologies' system-level integration expertise.

Labcorp acquires MLM Medical Labs to expand clinical trial network

Labcorp's acquisition of MLM Medical Labs extends its central laboratory footprint, making it the only central lab provider with a wholly owned network spanning North America, Europe, Asia and Africa for biomarker and clinical trial services.

Gastech 2026 Opens in Bangkok as Asia Drives 80% of Energy Demand Growth

Image
Gastech 2026 Opens in Bangkok as Asia Drives 80% of Energy Demand Growth

Bangkok – September 17, 2026 -- Gastech 2026 opens in Bangkok on September 14, convening 19 government ministers, global energy CEOs and technology leaders to address emerging markets that now drive more than 80% of global energy demand growth. Hosted by Thailand's Ministry of Energy and running through September 17, the event follows Gastech 2025's approximately $60 billion in commercial agreements and investments, setting a high bar for deal-making in this edition.

FDA Grants Orphan Drug Status to Lundbeck's Cushing's Antibody Asedebart

Valby, Denmark – – September 17, 2026 -- The U.S. Food and Drug Administration has granted Orphan Drug Designation to asedebart (Lu AG13909), Lundbeck's investigational anti-ACTH monoclonal antibody, for the treatment of endogenous Cushing's syndrome.

FDA designation adds U.S. market exclusivity potential for Lundbeck's rare disease pipeline

The designation covers drugs and biologics intended for rare diseases and can provide tax credits for qualified clinical testing, exemption from certain FDA application fees, and up to seven years of market exclusivity if the drug is approved for the designated indication.

Alpha Ladder WealthX Launches xStocks Tokenised Equities in Asia

Image
Alpha Ladder WealthX Launches xStocks Tokenised Equities in Asia

Singapore – September 17, 2026 -- Alpha Ladder Finance Pte. Ltd. has launched access to Payward's xStocks tokenised equities for institutional and accredited investors through its Alpha Ladder WealthX platform, becoming one of the first licensed wealth management firms in Asia to offer such access.

Alpha Ladder becomes a regional distribution partner for xStocks under a new MOU

The launch follows a Memorandum of Understanding between Alpha Ladder, MetaComp and Payward to advance tokenised capital markets across APAC. Under the arrangement, Alpha Ladder will distribute xStocks to institutional and accredited investors in selected regional markets, subject to eligibility, onboarding and compliance requirements.

EquipmentShare Hit With Securities Fraud Suit Over Hidden Deals

Los Angeles – September 17, 2026 -- DJS Law Group has reminded shareholders of a class action lawsuit filed against EquipmentShare.com Inc. (NASDAQ: EQPT), alleging the company violated federal securities law by concealing related-party transactions from investors.

Class Period Covers January 23 to September 17, 2026

The lawsuit, brought under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5, covers investors who purchased EquipmentShare stock between September 17, 2026 and September 17, 2026. Shareholders who suffered losses on trades within this window may be eligible to join the litigation.

Missouri Law HB 2974 Speeds Licensing, Expands Telehealth Access

Image
Missouri Law HB 2974 Speeds Licensing, Expands Telehealth Access

Kansas City, Mo. – September 17, 2026 -- Missouri Governor Mike Kehoe joined nonpartisan think tank United WE at its Kansas City headquarters on September 10 for a ceremonial signing of House Bill 2974, a law that shortens licensing wait times for out-of-state professionals and clarifies telehealth rules for providers with reciprocal Missouri licenses. The bill was formally signed on July 13 and took effect August 28.

HB 2974 resolves ambiguity blocking telehealth providers from treating Missouri patients

The law confirms that a health care provider granted a Missouri license based on an out-of-state credential is fully licensed in the state, including for delivering care to Missouri patients via telehealth. The previous statute, in place since 2018, had left that question unresolved.

MegazoneCloud Builds AI QA Agent for Hanmi Pharmaceutical

Seoul -- September 17, 2026 -- MegazoneCloud has begun system development on 'Hanmi Q-Agent,' an AI agent designed to cut Hanmi Pharmaceutical's quality assurance document workload by more than 40%, with build work starting September 7.

MegazoneCloud deploys RAG-based agent across 4,000 quality documents

The Seoul-based AI and cloud company will build a search-based AI agent covering roughly 4,000 quality documents accumulated by Hanmi Pharmaceutical, using its enterprise AI OS 'AIR Studio.' The retrieval-augmented generation (RAG) system will retrieve and summarize documents, then compare them against the latest pharmaceutical regulations to flag non-conforming items.